Table 3. PIK3CA, PTEN and BMI in the WUSTL sequencing cohort.
| Sample | PIK3CA | PTEN | BMI | HPV subtype |
|---|---|---|---|---|
| 705973 | p.E545K | CN Loss | 18.3 | HPV 52 |
| 760832 | p.E542K | WT | 18.8 | HPV 16 |
| 724788 | p.E39K | WT | 23.2 | HPV 16, HPV 18 |
| 727879 | p.E545K | WT | 23.2 | HPV 16 |
| 740838 | p.E545K | WT | 23.2 | HPV 18 |
| 704786 | p.E542Q | WT | 23.7 | HPV 16 |
| 707755 | WT | CN Loss | 24 | HPV 16 |
| 734998 | p.E545k, p.Q879* | WT | 24.4 | HPV 31 |
| 733024 | p.H1047R | WT | 25.2 | HPV 16 |
| 703822 | p.E545K | WT | 25.5 | HPV 16 |
| 722396 | p.E545K | WT | 25.5 | HPV 16 |
| 710808 | WT | CN Loss | 26 | Many |
| 704849 | WT | CN Loss | 26.1 | HPV 16 |
| 711380 | WT | CN Loss | 26.6 | Negative |
| 736133 | p.E545K | WT | 31.6 | HPV 16 |
| 720170 | WT | p.R233* | 31.8 | Negative |
| 704821 | p.E81K | WT | 32.1 | HPV 16 |
| 704956 | p.E493K, p.E476Q, p.E494K | WT | 35 | HPV 58 |
| 728723 | p.E81K | WT | 35.7 | HPV 16 |
| 720059 | p.E545K | WT | 37.3 | Negative |
| 714694 | p.E545.K | WT | 37.6 | HPV 16 |
| 731976 | WT | p.R130Q | 39.1 | HPV 16 |
| 733384 | WT | CN Loss | 39.7 | HPV 33 |
| 714960 | p.E542K | WT | 39.9 | HPV 16 |
| 736462 | p.E545K | WT | 43.2 | HPV 16 |
| 711012 | p.E545K | WT | 43.5 | HPV 16 |
| 738147 | p.C420R | p.R130G, CN Loss | 45 | Negative |
| 707913 | WT | CN Loss | 47.1 | HPV 16 |
| 755439 | p.E545K | WT | 47.1 | Many |
| 746486 | WT | p.T319fs | 56.5 | Negative |